Health

Obama’s Reforms Give States a Shot at Coming Out Winners

Obama’s Reforms Give States a Shot at Coming Out Winners

Health care reform demonstrates President Obama’s evolving understand of federalism.

Member of Congress Highlights Lack of Regulation of Potentially Dangerous Flu Research

Member of Congress Highlights Lack of Regulation of Potentially Dangerous Flu Research

Rep. Sensenbrenner spotlights controversial avian flu studies.

Nudging Smokers Away from Tobacco Risks

Nudging Smokers Away from Tobacco Risks

Tobacco regulation increasingly takes a behavioral turn.

Religious Liberty Advocates Challenge Contraception Mandate

Religious Liberty Advocates Challenge Contraception Mandate

The Becket Fund claims Obama’s health care regulation violates federal law.

Court Misapplies First Amendment to Strike Down FDA Cigarette Warning Labels

Court Misapplies First Amendment to Strike Down FDA Cigarette Warning Labels

A district court judge invents strict scrutiny requirement for commercial speech.

Bill to Kill ‘Death Panel’ Passes House Subcommittee

Bill to Kill ‘Death Panel’ Passes House Subcommittee

Bipartisan vote moves forward a bill repealing Obamacare’s Medicare cost-cutting body.

A Pill Everyone Can Swallow

A Pill Everyone Can Swallow

The FDA’s proposal to modernize generic drug approvals meets with broad support.

Senators Introduce Bipartisan Bill to Streamline Medical Device Approval

Senators Introduce Bipartisan Bill to Streamline Medical Device Approval

New bill would allow manufacturers of certain medical device to bypass elements of FDA’s existing process.

An Incomplete Contraceptive Coverage Compromise

An Incomplete Contraceptive Coverage Compromise

Despite political assurances, nothing has changed legally in the contraceptive insurance controversy.

Controversy Surrounds HHS Contraception Mandate

Controversy Surrounds HHS Contraception Mandate

President’s advisers signal willingness to “work with religious groups.”

FDA Submits User-Fee Recommendations to Congress

FDA Submits User-Fee Recommendations to Congress

Agency recommends statutory language for imposing user fees on biosimilar drug manufacturers.

FDA Warns Patients of Stem Cell Scams

FDA Warns Patients of Stem Cell Scams

The FDA cautions patients to undergo only approved stem cell treatments.